In summary, diabetic nephropathy is characterized by a multifactorial disea
se process. The present survey points to several factors that are treatable
by available drugs. We must now consider prophylactic treatment of patient
s with poor metabolic control not only to lower blood glucose levels, but a
lso to protect against the harmful effects of glucose. ACE inhibitors and s
everal other available drugs have such effects.